Meta's pivot from metaverse to AI represents a massive capital reallocation that could benefit the entire AI supply chain. When tech giants change direction, opportunities follow.
These companies provide the essential building blocks for AI - from the chips that power machine learning to the cloud platforms that deliver AI services to millions.
Each stock was carefully chosen by experts for its critical role in the AI ecosystem. This isn't random selection - it's strategic exposure to AI's most important players.
Meta's significant pivot from metaverse investments to artificial intelligence signals a broader industry shift. This reallocation of billions towards AI creates substantial opportunities for companies across the entire AI value chain, from chip manufacturers to cloud providers.
This group spans the complete AI ecosystem - semiconductor designers, data centre infrastructure providers, cloud computing giants, and AI software specialists. These companies are positioned to benefit directly from increased investment as tech leaders prioritise AI over speculative projects.
Each stock was handpicked by professional analysts for its critical role in the AI supply chain. From NVIDIA's essential GPUs to Microsoft's Azure platform, these companies provide the foundational technology that makes artificial intelligence possible.
Meta is significantly reducing its investment in the metaverse to focus on the more promising field of artificial intelligence. This strategic shift could boost companies that are critical to the AI supply chain, from chipmakers to software developers.
This basket's total market capitalisation is 18,614,021.68 and is heavily anchored by several very large-cap stocks, giving it a concentrated, large-cap profile that tends to be less volatile than smaller-cap baskets.
NVDA: $4.49T
META: $1.62T
MSFT: $3.55T
์ด ๋ฐ์ค์ผ์ ์ ์ฒด ์คํ ๋ฆฌ๋ฅผ ํ์ธํ์ธ์. ๋ฆฌ์คํฌ์ ์ ์ฌ๋ ฅ์ ๋ค๋ฃฌ ์์ธ ๊ธฐ์ฌ๋ฅผ ์ฝ์ด๋ณด์ธ์.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+6
Here are a few of the assets in this group. Create an account to unlock the full list.
์ด ๊ทธ๋ฃน์ ์์ฐ 16๊ฐ ์ค 14๊ฐ๊ฐ ์ ๋ฌธ ์ ๋๋ฆฌ์คํธ๋ก๋ถํฐ ๋งค์ ์๊ฒฌ์ ๋ฐ์์ต๋๋ค.
